Summary
The long term efficacy of class I antiarrhythmic drugs and of amiodarone was investigated in 34 patients with severe organic heart disease accompanied by frequent complex ventricular arrhythmias. All patients had undergone cardiac catheterisation which included coronary angiography, and each patient underwent a short and a long term study phase. During the short term study 6 class I antiarrhythmic agents were administered orally in a randomised. single-blind fashion. The drugs investigated were disopyramide. flecainide, mexiletine, prajmalium, propafenon and tocainide. The response was judged to be effective when there was a 90% reduction of couplets and a 100% reduction of salvos. For long term treatment the patient was given one of the agents found to be effective in the short term testing. Holier monitoring was performed after 1 week, and 1, 3 and 6 months. If the drug administered initially was later found to be ineffective, the patient was given another effective class I agent. If during the short term study or the follow-up phase there was no positive response to any class I agent, the patient was given amiodarone.
In 78% of the patients, one or more of the class I agents administered short term was effective. The percentage of effectively treated patients after 1 week was 56%, and was 28. 14, and 9% after 1, 3, and 6 months’ treatment, respectively. In amiodarone-treated patients there was an effective response rate of 40% after 10 days, 50% after I month and 70% after 3 and 6 months.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abinader E,G, and Cooper M,: Use in control of chronic drugresistant ventricular arrhythmia, Journal of the American Medical Association 242: 337–443 (1979)
Anderson J,L,; Stewart J,R, and Crevey B,J,: A proposal for the clinical use of flecainide, American Journal of Cardiology 53: 66b–71b(1984)
Blanco M,V,; Milei J,; Pineiro D,J,; Buceta J,E, and Dreyer M,P,: Long-term treatment of ventricular tachycardia in ambulatory patients with amiodarone, Acta Cardiologica 38: 125–132 (1983)
Duff, H,J,; Roden D,M,; Maffucci R,J,; Vesper B,S,; Conrad G,J,; Higgins S,B,; Oates J,A,; Smith R, and Woosley R,L,: Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide, American Journal of Cardiology 48: 1133–1140(1981)
Flecainide-Quinidine Research Group: Flecainide versus quinidine for treatment of chronic ventricular arrhythmias, A multicenter clinical test, Circulation 67: 1117–1123 (1983)
Fogoros R,N,; Anderson K,P,; Winkle R,A,; Swerdlow CD, and Mason J,W,: Amiodarone: Clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias, Circulation 68: 88–94(1983)
Graboys T,B,; Lown B,; Podrid P,J, and De Silva R,: Longterm survival of patients with malignant ventricular arrhythmias treated with antiarrhythmic drugs, American Journal of Cardiology 50: 437–443 (1982)
Haffajee C,I,; Sacks G,M,; Alpert J,S,; Howe J,P,; Ockene I,S,; Paraskos J,A, and Dalen J,E,: Chronic tocainide therapy for refractory high-grade ventricular arrhythmias, Clinical Cardiology 6: 72–78(1983)
Haffajee C: Klinische Pharmakokinetik oraler Amiodarone-Gaben; in Breilhardt and Loogen (Eds) Neue Aspekte in der medikamentösen Behandlung von Tachyarrhythmien —Bedeutung von Amiodarone, 63–74 (Urban & Schwarzenberg, München 1983)
Hodges M,; Salerno D,M,; Granrud G, and Flecainide-Quinidine Research Group: Flecainide versus quinidine: Results of a multicenter trial, American Journal of Cardiology 53: 66b–71b (1984)
Kaski J,C,; Girolti L,A,; Messuti H,; Rutzitzky B,; Rosenbaum M,B,: Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone, Circulation 64: 273–279(1981)
Kosowsky B,D,; Taylor J,; Lown B, and Ritchie R,F,: Longterm use of procaine amide following acute myocardial infarction, Circulation 47: 1204–1210 (1973)
Lown B, and Graboys T,B,: Management of patients with malignant ventricular arrhythmias, American Journal of Cardiology 39: 910–918 (1977)
Morganroth J,; Michelson EX,; Horowitz L,N,; Josephson M,E,; Pearlman A,S, and Dunkman W,B,: Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency, Circulation 58: 408–413 (1978)
Nademanee K,; Singh B,N,; Hendrickson J,; Intraachot V,; Lopez B,; Feld G,; Cannom D,S, and Weiss J,L,: Amiodarone in refractory life-threatening ventricular arrhythmias, Annals of Internal Medicine 98: 577–584 (1983)
Reid, P,R,; Griffith L,S,C,; Platia E,V, and Ord S,E,: Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death, American Journal of Cardiology 53: 108b–111b (1984), auSchmidt, G,; Weixel, G,; Goedel-Meinen, L,; Jahns, G,; Klein, G, and Wirtzfeld, A,: Analysegenauigkeit des Holtersystems ICR 6201-G-3, Herz-Kreislauf (in press, 1985)
Stein, J,; Podrid P,J,; Lampert S,; Hirsowitz G, and Lown B,: Long-term mexiletine for ventricular arrhythmia, American Heart Journal 107: 1091–1098(1984)
Wang, R,Y,C,; Lee P,K,; Wong K,L, and Chow M,S,S,: Mexiletine in the treatment of recurrent ventricular tachycardia, Prediction of long-term arrhythmia suppression from acute and short-term response, Journal of Clinical Pharmacology 23: 89–92 (1983)
Winkle, R,A,; Alderman EX,; Fitzgerald J,W, and Harrison D,C,: Treatment of recurrent symptomatic ventricular tachycardia, Annals of Internal Medicine 85: 1–7 (1976)
Winkle R,A,; Gradman A,H,; Fitzgerald J,W, and Bell P,A,: Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: Comparison of propranolol, procainamide and quinidine, American Journal of Cardiology 42: 473–480 (1978a)
Winkle R,A,; Meffin P,A, and Harrison D,C,: Long-term tocainide therapy for ventricular arrhythmias, Circulation 57: 1008–1016 (1978b)
Author information
Authors and Affiliations
Additional information
Amiodarone is marketed by Sanofi Labaz under the trademarks Cordarone (France), Cordarex (Germany), Cordarone-X (UK), Trangorex (Spain), Amiodar (Italy)
Rights and permissions
About this article
Cite this article
Schmidt, G., Goedel-Meinen, L., Jahns, G. et al. Long Term Efficacy of Class I Antiarrhythmic Agents and Amiodarone in Patients with Malignant Ventricular Arrhythmias. Molecular Diagnosis 29 (Suppl 3), 37–46 (1985). https://doi.org/10.2165/00003495-198500293-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198500293-00006